Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT02508402
Eligibility Criteria:
Inclusion Criteria:
* Singleton pregnancy.
* Primigravida.
* Post-term gestation i.e. 41 weeks or more.
* Sure, reliable dates.
* Favorable cervix with Bishop score of 7 or greater.
* Longitudinal lie.
* Cephalic presentation (Vertex).
Exclusion Criteria:
* Abnormal presentation.
* Multigravida.
* Multiple pregnancies.
* Active phase of labour.
* Cephalo-pelvic disproportion.
* History of any medical disorder.
* History of previous myomectomy operation.
* Known contraindication or hypersensitivity to Dexamethasone.
* Current fetal distress.
* Current maternal or fetal disorder e.g. Diabetes mellitus; Pregnancy induced hypertension, and fetal growth retardation.
* Over distended abdomen e.g. fetal macrosomia or polyhydramnios suggested by ultrasound or estimated fetal weight by expert hand.
* Significant vaginal bleeding.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT02508402
Study Brief:
Protocol Section:
NCT02508402